Document Detail


Percutaneous transluminal angioplasty for atheromatous renal artery stenosis--blood pressure response and discriminant analysis of outcome predictors.
MedLine Citation:
PMID:  2143839     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Percutaneous transluminal angioplasty was performed in 39 consecutive patients with atheromatous renal artery stenosis associated with hypertension. The mean blood pressure before angioplasty was 191/107 mmHg and this had dropped to a mean of 167/90 mmHg at the patient's most recent visit, representing a significant fall in both systolic (p less than 0.01) and diastolic pressures (p less than 0.001). The mean serum creatinine was 166.7 mumol/l before percutaneous transluminal angioplasty and 155.3 mumol/l at the most recent visit (not statistically significant). The mean number of anti-hypertensive drugs fell from 2.4 to 1.9 after percutaneous transluminal angioplasty (p less than 0.05). Three patients (eight per cent) were 'cured' (diastolic blood pressure less than 90 mmHg without medication), 25 (64 per cent) had 'improved' (diastolic blood pressure less than 109 mmHg, with a fall of more than 15 per cent) and 11 (28 per cent) had not improved. Logistic discriminant analysis showed that pre-percutaneous transluminal angioplasty diastolic blood pressure, age, serum creatinine and smoking habit together correctly predicted the outcome of percutaneous transluminal angioplasty in 90 per cent of patients, with four 'false positives' and no 'false negatives'. Ten patients suffered a total of 12 serious complications related to the procedure: one death in acute renal failure, one myocardial infarction, one severe hypotension just after the procedure, one deep vein thrombosis, one episode of transient ischaemia of the toes and seven groin haematomas. Thus percutaneous transluminal angioplasty for atheromatous renal artery stenosis rarely 'cures' hypertension, but improved blood pressure control is often achieved, albeit at the expense of troublesome complications. A prospective, randomized trial is needed to establish whether or not the improvement is due directly to percutaneous transluminal angioplasty.
Authors:
F I Marshall; S Hagen; R G Mahaffy; J C Petrie; P Roy-Chaudhury; I T Russell; J Webster
Related Documents :
23533459 - Nigella sativa and its protective role in oxidative stress and hypertension.
19424279 - Telmisartan predominantly suppresses cardiac fibrosis, rather than hypertrophy, in reno...
8948319 - Secondary hypertension: evaluation and treatment.
17965509 - Pressure wave reflection after successful balloon dilatation of aortic coarctation.
22170769 - The impact of hepatic pressurization on liver shear wave speed estimates in constrained...
15760859 - Possible electrical stimulation on rostral ventrolateral medulla that causes significan...
999549 - Response to topical epinephrine. a practical prognostic test in patients with ocular hy...
2031069 - Anger-coping styles and blood pressure in black and white males: buffalo, new york.
10639199 - Ventilation inhomogeneity assessed by nitrogen washout and ventilation-perfusion mismat...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The Quarterly journal of medicine     Volume:  75     ISSN:  0033-5622     ISO Abbreviation:  Q. J. Med.     Publication Date:  1990 May 
Date Detail:
Created Date:  1990-09-24     Completed Date:  1990-09-24     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0401027     Medline TA:  Q J Med     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  483-9     Citation Subset:  IM    
Affiliation:
Department of Medicine and Therapeutics, University of Aberdeen.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Age Factors
Aged
Angioplasty, Balloon*
Arteriosclerosis / therapy*
Blood Pressure*
Creatinine / blood
Discriminant Analysis
Female
Humans
Hypertension, Renal / etiology,  physiopathology*,  therapy
Male
Middle Aged
Renal Artery Obstruction / blood,  complications,  therapy*
Smoking
Time Factors
Chemical
Reg. No./Substance:
60-27-5/Creatinine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Apropos of the article by L.B. Shefer and A.D. Dzhunusbekov "The concept of a material incentive sys...
Next Document:  Hepatic inferior vena cava obstruction: treatment of two types with Gianturco expandable metallic st...